GHK-Cu gene expression study 2018 explained

The GHK-Cu gene expression study by Loren Pickart and Anna Margolina was published in July 2018 in the International Journal of Molecular Sciences. The paper is titled Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Loren Pickart is the biochemist who first isolated GHK from human plasma in the 1970s, so this paper is in part a summary of several decades of his own work. It tries to explain why one small peptide appears to have so many different biological effects. This article summarises what the authors asked, how they approached the question and what the paper does and does not show.

What the GHK-Cu gene expression study asked

GHK is a tripeptide with the sequence glycyl-L-histidyl-L-lysine. It binds copper ions strongly, and the copper complex is known as GHK-Cu. Over the years, laboratory studies have linked GHK to a long list of actions: blood vessel and nerve outgrowth, increased synthesis of collagen, elastin and glycosaminoglycans, and support for dermal fibroblasts, the cells that build skin connective tissue. Our GHK-Cu copper peptide guide explains the basics of the molecule.

The authors asked a specific question: can newer gene expression data explain how a single molecule produces such a wide range of protective and regenerative effects? Their hypothesis was that GHK does not act through one pathway but regulates many biochemical pathways at the level of gene activity.

How the GHK-Cu gene expression study was done

This paper is a review, not a new experiment. The authors collected published data on GHK and GHK-Cu from cell culture, animal and human studies, and combined this with gene expression data. The gene data they refer to come from analyses in which human cells were exposed to GHK and the change in activity of thousands of genes was measured, then compared with gene signatures of diseases and biological processes.

Because it is a review, the paper has no sample size, no control group and no statistical result of its own. Its value lies in bringing together findings from many different sources into one framework. Readers should keep in mind that the underlying experiments vary a great deal in design, quality and relevance.

What the GHK-Cu gene expression study found

The abstract lists the actions the authors attribute to GHK on the basis of the published literature. On the regenerative side, these are:

• Stimulation of blood vessel and nerve outgrowth

• Increased synthesis of collagen, elastin and glycosaminoglycans

• Support for the function of dermal fibroblasts

• Improved tissue repair in skin, lung connective tissue, bone, liver and stomach lining

On the protective side, the authors cite anti-inflammatory actions, several anti-cancer activities in laboratory settings, lung protection, restoration of fibroblasts from patients with chronic obstructive pulmonary disease, suppression of the transcription factor NF-kappa-B, DNA repair and activation of the proteasome system, which clears damaged proteins from cells. They also mention anti-anxiety, anti-pain and anti-aggression effects reported in animal studies.

The central conclusion of the paper is that recent genetic data may explain this diversity. According to the authors, the gene expression analyses show that GHK regulates multiple biochemical pathways at once, which would account for protective and healing actions in many different tissues. The abstract does not report individual numbers, such as how many genes were affected, so we do not state any here.

Limitations of the GHK-Cu gene expression study

A careful reader should weigh several limitations:

• Review design: The paper summarises existing work rather than testing a hypothesis in a new experiment. No new data were generated.

• Author involvement: Both authors are affiliated with a company that works commercially with GHK-Cu, and much of the cited evidence comes from the first author's own earlier research. The authors declare no conflict of interest, but readers should still be aware of this background.

• Mixed evidence levels: The claims range from cell culture data to small human skin studies. Gene expression changes in a dish do not prove that the same effects occur in a living organism.

• Breadth of claims: The abstract states that all known actions of GHK appear to be health positive. A list of effects this long and this uniformly favourable is unusual in biology and calls for independent confirmation.

• No replication: Many of the gene expression findings have not been repeated by independent groups.

What this means for GHK-Cu research

The paper is a useful map of the territory. It collects almost everything that had been published on GHK up to 2018 and proposes gene regulation as the common mechanism. For researchers, the most interesting leads are the specific pathways named in the paper, which can be tested one at a time in controlled experiments. The most pressing need is independent replication of the gene expression results and of the tissue repair findings in standardised animal models.

The review does not provide evidence for effects in people outside controlled studies, and it should not be read as a recommendation for any use. GHK-Cu is one of several compounds in our anti-aging and longevity peptides collection, and our GHK-Cu 50 mg is supplied as lyophilised powder for research use. Practical notes on dissolving peptides are in our guide on how to reconstitute peptides.

Sources

• Pickart L, Margolina A (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 19(7), 1987. doi:10.3390/ijms19071987

This article summarises published research for information only. It is not medical advice. All products on this site are sold for laboratory research use only and are not intended for human or veterinary use.